Lasa Supergeneri

{
  "main_header": {
    "sid": 1002834,
    "name": "Lasa Supergeneri",
    "stock_name": "Lasa Supergeneri",
    "full_name": "Lasa Supergenerics Ltd",
    "name_url": "stocks-analysis/lasa-supergeneri",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "7.68",
    "chg": -0.06,
    "chgp": "-0.78%",
    "dir": -1,
    "prev_price": "7.74",
    "mcapval": "37.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 540702,
    "symbol": "LASA",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE670X01014",
    "curr_date": "Mar 13",
    "curr_time": "",
    "bse_nse_vol": "82.66 k",
    "exc_status": "Active",
    "traded_date": "Mar 13, 2026",
    "traded_date_str": "2026 03 13",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/lasa-supergeneri-1002834-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Lasa Supergenerics Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/lasa-supergenerics-ltd-is-rated-strong-sell-3873097",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/LasaSupergeneri_mojoScore_3873097.png",
        "date": "2026-03-05 10:10:37",
        "description": "Lasa Supergenerics Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 11 February 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 05 March 2026, providing investors with an up-to-date perspective on the company’s performance and outlook."
      },
      {
        "title": "Lasa Supergenerics Ltd Stock Hits 52-Week Low at Rs.7.13",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lasa-supergenerics-ltd-stock-hits-52-week-low-at-rs713-3869722",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/LasaSupergeneri_priceRelatedfactors_3869722.png",
        "date": "2026-03-04 12:11:37",
        "description": "Lasa Supergenerics Ltd, a player in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of Rs.7.13, marking a significant decline in its stock price amid ongoing market pressures and company-specific financial concerns."
      },
      {
        "title": "Lasa Supergenerics Ltd Stock Hits 52-Week Low Amidst Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lasa-supergenerics-ltd-stock-hits-52-week-low-amidst-continued-downtrend-3869720",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/LasaSupergeneri_priceRelatedfactors_3869720.png",
        "date": "2026-03-04 12:11:34",
        "description": "Lasa Supergenerics Ltd, a player in the Pharmaceuticals & Biotechnology sector, has recorded a new 52-week low of Rs.7.13 today, marking a significant decline in its stock price amid ongoing market pressures and company-specific factors."
      },
      {
        "title": "Lasa Supergenerics Ltd Stock Falls to 52-Week Low of Rs.7.29",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lasa-supergenerics-ltd-stock-falls-to-52-week-low-of-rs729-3864898",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/LasaSupergeneri_priceRelatedfactors_3864898.png",
        "date": "2026-03-02 12:50:33",
        "description": "Lasa Supergenerics Ltd, a player in the Pharmaceuticals & Biotechnology sector, has touched a new 52-week and all-time low of Rs.7.29 today, marking a significant decline in its stock price amid ongoing market pressures and company-specific challenges."
      },
      {
        "title": "Lasa Supergenerics Ltd Stock Hits 52-Week Low Amidst Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lasa-supergenerics-ltd-stock-hits-52-week-low-amidst-continued-downtrend-3848435",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/LasaSupergeneri_priceRelatedfactors_3848435.png",
        "date": "2026-02-20 11:11:34",
        "description": "Lasa Supergenerics Ltd, a player in the Pharmaceuticals & Biotechnology sector, has touched a new 52-week and all-time low of Rs.7.59 today, marking a significant decline amid a broader market recovery. The stock has underperformed its sector and benchmark indices, reflecting ongoing financial pressures and subdued performance metrics."
      },
      {
        "title": "Lasa Supergenerics Ltd Stock Hits 52-Week Low Amid Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lasa-supergenerics-ltd-stock-hits-52-week-low-amid-continued-downtrend-3846979",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/LasaSupergeneri_priceRelatedfactors_3846979.png",
        "date": "2026-02-19 10:54:48",
        "description": "Lasa Supergenerics Ltd, a player in the Pharmaceuticals & Biotechnology sector, has touched a new 52-week low of Rs.7.7 today, marking a significant decline amid a sustained downward trend. The stock has underperformed its sector and broader market indices, reflecting ongoing pressures on its financial and operational metrics."
      },
      {
        "title": "Lasa Supergenerics Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/lasa-supergenerics-ltd-is-rated-strong-sell-3845543",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/LasaSupergeneri_mojoScore_3845543.png",
        "date": "2026-02-18 10:10:47",
        "description": "Lasa Supergenerics Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 11 February 2025. However, the analysis and financial metrics presented here reflect the stock’s current position as of 18 February 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Are Lasa Supergenerics Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-lasa-supergenerics-ltd-latest-results-good-or-bad-3840551",
        "imagepath": "",
        "date": "2026-02-14 19:55:45",
        "description": "Lasa Supergenerics Ltd's latest financial results for Q3 FY26 indicate significant operational challenges. The company reported a net profit of -₹2.55 crores, reflecting a substantial decline compared to the previous year, where it had a profit of ₹5.49 crores. This marks a drastic year-on-year decrease of 146.45%. Revenue for the same quarter plummeted to ₹2.20 crores, a staggering 93.35% drop from ₹33.08 crores in Q3 FY25, signaling a critical failure in the business model rather than just cyclical fluctuations.\n\nThe operating margin, excluding other income, deteriorated to -34.09%, down from a positive 0.82% in the prior year. This indicates that the company is incurring significant losses at the operational level before accounting for depreciation, interest, or taxes. The operational performance metrics show a consistent decline, with the company unable to generate meaningful revenue while maintaining h..."
      },
      {
        "title": "Lasa Supergenerics Q3 FY26: Revenue Collapse Signals Deepening Crisis",
        "link": "https://www.marketsmojo.com/news/result-analysis/lasa-supergenerics-q3-fy26-revenue-collapse-signals-deepening-crisis-3838938",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/LasaSupergeneri_quaterlyResult_3838938.png",
        "date": "2026-02-13 21:24:49",
        "description": "Lasa Supergenerics Limited has reported catastrophic Q3 FY26 results that underscore the pharmaceutical manufacturer's accelerating operational crisis. The company posted a net loss of ₹2.55 crores for the quarter ended December 2025, representing a 59.20% improvement from the previous quarter's loss of ₹6.25 crores but a dramatic reversal from the ₹5.49 crores profit recorded in Q3 FY25. With a market capitalisation of just ₹44.00 crores and shares trading at ₹8.81, the stock has plunged 64.75% over the past year, reflecting investor capitulation as fundamental deterioration continues unabated."
      }
    ],
    "total": 226,
    "sid": "1002834",
    "stock_news_url": "https://www.marketsmojo.com/news/lasa-supergenerics-1002834"
  },
  "announcements": [
    {
      "caption": "Results For Quarter Ended 31St December 2025",
      "datetime": "13-Feb-2026",
      "details": "Results for quarter ended 31st December 2025",
      "source": "BSE"
    },
    {
      "caption": "Integrated Filing For Quarter Ended December 31 2025",
      "datetime": "13-Feb-2026",
      "details": "Integrated filing for quarter ended December 31 2025",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of Board Meeting For Quarter Ended 31St December 2025",
      "datetime": "13-Feb-2026",
      "details": "Pursuant to Regulation 29 and 30 of SEBI (Listing obligation and disclosure requirements) Regulations 2015 we would like to inform you that the Board of Directors in their meeting held today which was commenced at 2.00 P.M. and concluded at 03.15 P.M. inter- alia have considered and approved the following: 1. The Unaudited Financial Results of the Company for the quarter ended December 31 2025. 2. Limited Review Report from Statutory Auditor for the quarter ended on December 31 2025.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Lasa Supergenerics Ltd has declared <strong>2%</strong> dividend, ex-date: 16 Sep 22",
          "dt": "2022-09-16",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Lasa Supergenerics Ltd is Rated Strong Sell

2026-03-05 10:10:37

Lasa Supergenerics Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 11 February 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 05 March 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.

Read full news article

Lasa Supergenerics Ltd Stock Hits 52-Week Low at Rs.7.13

2026-03-04 12:11:37

Lasa Supergenerics Ltd, a player in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of Rs.7.13, marking a significant decline in its stock price amid ongoing market pressures and company-specific financial concerns.

Read full news article

Lasa Supergenerics Ltd Stock Hits 52-Week Low Amidst Continued Downtrend

2026-03-04 12:11:34

Lasa Supergenerics Ltd, a player in the Pharmaceuticals & Biotechnology sector, has recorded a new 52-week low of Rs.7.13 today, marking a significant decline in its stock price amid ongoing market pressures and company-specific factors.

Read full news article

Lasa Supergenerics Ltd Stock Falls to 52-Week Low of Rs.7.29

2026-03-02 12:50:33

Lasa Supergenerics Ltd, a player in the Pharmaceuticals & Biotechnology sector, has touched a new 52-week and all-time low of Rs.7.29 today, marking a significant decline in its stock price amid ongoing market pressures and company-specific challenges.

Read full news article

Lasa Supergenerics Ltd Stock Hits 52-Week Low Amidst Continued Downtrend

2026-02-20 11:11:34

Lasa Supergenerics Ltd, a player in the Pharmaceuticals & Biotechnology sector, has touched a new 52-week and all-time low of Rs.7.59 today, marking a significant decline amid a broader market recovery. The stock has underperformed its sector and benchmark indices, reflecting ongoing financial pressures and subdued performance metrics.

Read full news article

Lasa Supergenerics Ltd Stock Hits 52-Week Low Amid Continued Downtrend

2026-02-19 10:54:48

Lasa Supergenerics Ltd, a player in the Pharmaceuticals & Biotechnology sector, has touched a new 52-week low of Rs.7.7 today, marking a significant decline amid a sustained downward trend. The stock has underperformed its sector and broader market indices, reflecting ongoing pressures on its financial and operational metrics.

Read full news article

Lasa Supergenerics Ltd is Rated Strong Sell

2026-02-18 10:10:47

Lasa Supergenerics Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 11 February 2025. However, the analysis and financial metrics presented here reflect the stock’s current position as of 18 February 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Are Lasa Supergenerics Ltd latest results good or bad?

2026-02-14 19:55:45

Lasa Supergenerics Ltd's latest financial results for Q3 FY26 indicate significant operational challenges. The company reported a net profit of -₹2.55 crores, reflecting a substantial decline compared to the previous year, where it had a profit of ₹5.49 crores. This marks a drastic year-on-year decrease of 146.45%. Revenue for the same quarter plummeted to ₹2.20 crores, a staggering 93.35% drop from ₹33.08 crores in Q3 FY25, signaling a critical failure in the business model rather than just cyclical fluctuations. The operating margin, excluding other income, deteriorated to -34.09%, down from a positive 0.82% in the prior year. This indicates that the company is incurring significant losses at the operational level before accounting for depreciation, interest, or taxes. The operational performance metrics show a consistent decline, with the company unable to generate meaningful revenue while maintaining h...

Read full news article

Lasa Supergenerics Q3 FY26: Revenue Collapse Signals Deepening Crisis

2026-02-13 21:24:49

Lasa Supergenerics Limited has reported catastrophic Q3 FY26 results that underscore the pharmaceutical manufacturer's accelerating operational crisis. The company posted a net loss of ₹2.55 crores for the quarter ended December 2025, representing a 59.20% improvement from the previous quarter's loss of ₹6.25 crores but a dramatic reversal from the ₹5.49 crores profit recorded in Q3 FY25. With a market capitalisation of just ₹44.00 crores and shares trading at ₹8.81, the stock has plunged 64.75% over the past year, reflecting investor capitulation as fundamental deterioration continues unabated.

Read full news article

View All News